關鍵數據
69.920今開
70.830最高
885.76K成交量
虧損本益比TTM
52.14本益比動
--股利TTM
2.99%換手率
68.960昨收
64.880最低
48.57M成交額
虧損本益比靜
7.60市淨率
0.00%股息率 TTM
-16.33%ROA
170.87052週最高
1.09量比
-52.29M淨利潤
29.67M總股本
-2.6604每股盈餘TTM
1.99Beta
-30.42%ROE
32.21052週最低
8.63%振幅
66.71%毛利率
1.93B總市值
0.03回報/風險
4.06%風險率
操作建議
GeneDx Holdings Corp當前公司基本面數據相對健康,增長潛力較大。當前估值合理,在醫療服務供應商行業排名11/75位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為92.89。中期看,股價處於上升通道。近一個月,市場表現較差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
GeneDx Holdings Corp亮點
亮點風險
GeneDx Holdings Corp新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
GeneDx Holdings Corp簡介
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
公司代碼WGS
公司GeneDx Holdings Corp
CEOStueland (Katherine A)
網址https://sema4.com/
公司股東
常見問題
GeneDx Holdings Corp(WGS)的當前股價是多少?
GeneDx Holdings Corp(WGS)的當前股價是 65.11。
GeneDx Holdings Corp 的股票代碼是什麼?
GeneDx Holdings Corp的股票代碼是WGS。
GeneDx Holdings Corp股票的52週最高點是多少?
GeneDx Holdings Corp股票的52週最高點是170.87。
GeneDx Holdings Corp股票的52週最低點是多少?
GeneDx Holdings Corp股票的52週最低點是32.21。
GeneDx Holdings Corp的市值是多少?
GeneDx Holdings Corp的市值是1.93B。
現在GeneDx Holdings Corp(WGS)的股票是買入、持有還是賣出?
根據分析師評級,GeneDx Holdings Corp(WGS)的總體評級為買入,目標價格為92.89。
GeneDx Holdings Corp(WGS)股票的每股收益(EPS TTM)是多少
GeneDx Holdings Corp(WGS)股票的每股收益(EPS TTM)是-0.73。